J. of Supercritical Fluids 51 (2009) 50–56
Contents lists available at ScienceDirect
The Journal of Supercritical Fluids
journal homepage: www.elsevier.com/locate/supflu
The supercritical micronization of solid dispersions by Particles from Gas
Saturated Solutions using experimental design
Michael Brion
a,∗
, Séverine Jaspart
a
, Leonardo Perrone
b
, Géraldine Piel
a
, Brigitte Evrard
a
a
Laboratory of Pharmaceutical Technology, Pharmacy Department, CIRM, University of Liège, 4000 Liège, Belgium
b
Laboratory of Pharmaceutical Technology, Pharmacy Department, University of Camerino, 62032 Camerino (MC), Italy
article info
Article history:
Received 17 April 2009
Received in revised form 29 June 2009
Accepted 30 June 2009
Keywords:
Experimental design
Plackett–Burman
Central composite design
Supercritical carbon dioxide
Solid dispersion
Particles from Gas Saturated Solutions
abstract
The Particle from Gas Saturated Solutions process was successfully used to micronize solid dispersions
containing hydrophilic carriers and a new chemical entity, YNS3107. By means of experimental design, the
effects of several experimental parameters on micronization were investigated. Within the chosen exper-
imental conditions, the results showed that the autoclave temperature, autoclave pressure, drug loading,
flow rate of carbon dioxide and air pressure were significant parameters. During the optimization step, the
most relevant parameters of the screening were optimized using a central composite design meanwhile
other factors were kept constant. Optimal conditions were used to produce microparticles with a volume
weighted mean diameter of 30.4 m. The closeness between the measured and predicted response, eval-
uated at 28.1 m, demonstrated the validity of the statistical analyses. Finally, an enhancement of the rate
of dissolution of YNS3107 in the solid dispersion microparticles was measured using USP II dissolution
test apparatus.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
In most cases, oral administration of new chemical entities (NCE)
results in poor bioavailability because of their poor water-solubility
and low dissolution rate. Solid dispersions have been widely used
to improve these specific properties [1–3]. Generally, a solid dis-
persion (SD) is a dispersion of one or more hydrophobic drug(s) in
a polymeric hydrophilic matrix at a solid state. These drugs can be
dispersed molecularly, in clusters or in a combination of both. Such
dosage forms are conventionally prepared by the fusion, solvent or
fusion–solvent method.
Supercritical micronization processes, such as rapid expansion
of a supercritical solution [4,5] (RESS), supercritical anti-solvent
[6,7] (SAS) or Particles from Gas Saturated Solutions [8–14]
(PGSS
TM
), have gained increasing attention and may be considered
as interesting alternatives for the micronization of solid dispersions.
The Particle from Gas Saturated Solutions process, in particular,
exhibits some important advantages such as the fact that drug(s)
and carrier(s) do not require a high solubility in supercritical fluid
(SCF), the fact that it is a one-step process and the fact that it
provides the possibility of avoiding the use of organic solvents.
However, the SCF, generally supercritical carbon dioxide (scCO
2
),
∗
Corresponding author at: Avenue de l’hopital, 1, B36, Tour 4, +2, 4000 Liège,
Belgium. Tel.: +32 4 366 4306; fax: +32 4 366 4301.
E-mail address: mbrion@ulg.ac.be (M. Brion).
must be soluble [15] in the solid matrix in order to obtain a molten
system for the micronization.
The present study intends to investigate, by using design of
experiments, the effects of several experimental parameters on
the supercritical micronization of solid dispersions containing
polymeric excipients (PEG4000, PEG400 and poloxamer 407) and
YNS3107. During the optimization, the appropriate mathematical
model describing the Particle from Gas Saturated Solutions process
was elaborated and used in order to find the optimal conditions of
micronization producing the smallest SD microparticles. Finally, the
dissolution profiles of the produced microparticles, the correspond-
ing physical mixture and pure active ingredient were compared.
2. Materials and methods
2.1. Materials
CO
2
(99.998%) was supplied by Air Liquide (Liège, Belgium)
and YNS3107 by UCB Pharma S.A. (Braine-l’Alleud, Belgium).
Methanol (LiChrosolv
®
), acetonitrile (LiChrosolv
®
), polyethylene
glycol M
w
∼ 4000 (PEG4000), potassium dihydrogen phosphate
(pro-analysis quality), dipotassium hydrogen phosphate (pro-
analysis quality) and polysorbate 80 were purchased from Merck
(Darmstadt, Germany). Polyethylene glycol M
w
∼ 400 (PEG400),
sodium hydroxide pellets (Ph. Eur.) and poloxamer 407 were pro-
vided by Fagron (Waregem, Belgium), VWR (Leuven, Belgium) and
BASF (Burgbernheim, Germany), respectively. All products were
0896-8446/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.supflu.2009.06.021